NMPA Approval

Osimertinib Mesylate Tablets

Approval Number

国药准字HJ20181063

Registration Date

August 30, 2021

Previous Approval Numbers

H20181063

Drug Information

Generic Name

甲磺酸奥希替尼片

Trade Name

泰瑞沙

Brand Name

泰瑞沙

Dosage Form

片剂

Strength

80mg(按C28H33N7O2计)

Drug Type

化学药品

Registration Date

August 30, 2021

Expiry Date

August 29, 2026

Company Address

SE-151 85 Sodertalje, Sweden

Company Address

Gartunavagen, SE-151 85 Sodertalje, Sweden

Empowering clinical research with data-driven insights and AI-powered tools.

甲磺酸奥希替尼片 - NMPA 批准文号 | MedPath